Australia markets closed

Monopar Therapeutics Inc. (MNPR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.6100+0.0600 (+1.32%)
At close: 04:00PM EDT
4.6800 +0.07 (+1.52%)
After hours: 06:23PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
4,449
5,600
7,592
6,493
4,065
Selling general and administrative
3,041
3,231
2,945
2,634
2,444
Total operating expenses
7,490
8,831
10,537
9,127
6,509
Operating income or loss
-7,490
-8,831
-10,537
-9,127
-6,509
Total other income/expenses net
-
-
-
-
122.4
Income before tax
-7,124
-8,402
-10,516
-9,103
-6,305
Income from continuing operations
-7,124
-8,402
-10,516
-9,103
-6,305
Net income
-7,124
-8,402
-10,516
-9,103
-6,305
Net income available to common shareholders
-7,124
-8,402
-10,516
-9,103
-6,305
Basic EPS
-0.72
-3.05
-4.15
-3.65
-2.90
Diluted EPS
-0.72
-3.05
-4.15
-3.65
-2.90
Basic average shares
13,384
2,765
2,544
2,494
2,192
Diluted average shares
13,384
2,765
2,544
2,494
2,192